Back

Ablation efficacy and safety in elderly vs. super-elderly with atrial fibrillation: insights from the prospective multicenter REAL-AF registry

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and stroke Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Chang Dai

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
Participation rate in opportunistic screening compared to systematic screening for atrial fibrillation: STROKESTOP III
Miss S. Skroder (Orebro, SE)
Abstract Slides Video
Presentation thumbnail
The efficacy and safety of apixaban use in chronic liver disease: a secondary analysis of the ARISTOTLE trial
Doctor B. Suleiman (Durham, US)
Abstract Slides Video
Presentation thumbnail
A quantitative comparison of left- versus right-atrial intracardiac echocardiography for pulmonary vein visualization: a prospective single-center study
Doctor M. Pak (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Pharmacologic and non-pharmacologic interventions for preventing postoperative atrial fibrillation in cardiac surgery: systematic review and network meta-analysis
Doctor C. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Concurrent DOAC and rate control therapy in atrial fibrillation: nationwide time-dependent outcome analysis
Associate Professor R. Arbel (Tel Aviv, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and stroke

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Longterm 13 Year Outcome of AF Ablation in Elderly Patients - German Ablation Registry
2 September 2024
thumbnail
Congress Presentation
Impact of substrate modification and shift in recurrence pattern in elderly patients with persistent atrial fibrillation: a sub-analysis of the SUPPRESS-AF trial
29 August 2026
thumbnail
Congress Presentation
Direct oral anticoagulants in very elderly (≥90 years) patients with atrial fibrillation: observed versus predicted thromboembolism and bleeding risk, and HAS-BLED performance
29 August 2026
thumbnail
Congress Presentation
Early catheter ablation for atrial fibrillation in acute heart failure: prognostic impact across age and ejection fraction
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources